4bases - Precision Genomic Diagnostics Partner

Company Overview:
4bases is a Swiss company founded in 2013, specializing in the development and production of clinically validated, CE IVD certified genetic diagnostic solutions. The company focuses on precision genomics for cancer detection, genetic disease identification, and transplant monitoring. 4bases combines advanced NGS technology with expert bioinformatics to deliver actionable genomic insights for clinical decision-making.

Product Specialties & Applications:
4bases offers NGS-based diagnostic panels for cancer genomics, genetic disease detection, and transplant rejection monitoring. Their InnoGraft solution provides robust detection of donor DNA at very low levels, compatible with multiple NGS platforms. The company also operates 4baseCare, which provides comprehensive genomic insights through tissue profiling for solid tumor genomics and deep tumor sequencing for precise therapeutic guidance. 4bases has established strategic partnerships with Oxford Nanopore for long-read sequencing capabilities and Saphetor for advanced data analysis and interpretation through VarSome Clinical.

Alignment with Mega Life Science:
4bases' CE IVD certified genomic diagnostic panels strengthen Mega Life Science's distribution portfolio with clinically validated solutions for precision medicine. By offering 4bases' NGS-based panels and bioinformatics services, Mega Life Science provides customers with comprehensive genomic profiling options for oncology, genetic disease diagnosis, and transplant monitoring. This partnership enables Mega Life Science to deliver complete, validated diagnostic solutions to clinical laboratories and research institutions.

Website: https://4bases.ch/